Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

Jonas Cerneckis,Hongxia Cai,Yanhong Shi
DOI: https://doi.org/10.1038/s41392-024-01809-0
IF: 39.3
2024-04-27
Signal Transduction and Targeted Therapy
Abstract:The induced pluripotent stem cell (iPSC) technology has transformed in vitro research and holds great promise to advance regenerative medicine. iPSCs have the capacity for an almost unlimited expansion, are amenable to genetic engineering, and can be differentiated into most somatic cell types. iPSCs have been widely applied to model human development and diseases, perform drug screening, and develop cell therapies. In this review, we outline key developments in the iPSC field and highlight the immense versatility of the iPSC technology for in vitro modeling and therapeutic applications. We begin by discussing the pivotal discoveries that revealed the potential of a somatic cell nucleus for reprogramming and led to successful generation of iPSCs. We consider the molecular mechanisms and dynamics of somatic cell reprogramming as well as the numerous methods available to induce pluripotency. Subsequently, we discuss various iPSC-based cellular models, from mono-cultures of a single cell type to complex three-dimensional organoids, and how these models can be applied to elucidate the mechanisms of human development and diseases. We use examples of neurological disorders, coronavirus disease 2019 (COVID-19), and cancer to highlight the diversity of disease-specific phenotypes that can be modeled using iPSC-derived cells. We also consider how iPSC-derived cellular models can be used in high-throughput drug screening and drug toxicity studies. Finally, we discuss the process of developing autologous and allogeneic iPSC-based cell therapies and their potential to alleviate human diseases.
biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?
The problem this paper attempts to address is: The development of induced pluripotent stem cell (iPSC) technology offers tremendous opportunities for studying human biology in vitro and for cell therapy applications. This paper reviews key advances in the iPSC field, highlighting the great flexibility of iPSC technology in in vitro modeling and therapeutic applications. Specifically, the paper discusses the following aspects: 1. **Historical Background**: Reviews the key discoveries that led to the successful generation of iPSCs in 2006 and 2007, including the potential for nuclear reprogramming. 2. **Molecular Mechanisms**: Explores the molecular mechanisms and dynamics of somatic cell reprogramming to iPSCs, as well as various methods of inducing pluripotency. 3. **Range of Applications**: - **In Vitro Modeling**: From single-cell type monocultures to complex 3D organoids, iPSC-derived cell models can be used to elucidate mechanisms of human development and disease. - **Drug Screening**: iPSC-derived cell models can be used for high-throughput drug screening and drug toxicity studies. - **Cell Therapy**: Discusses the development process of autologous and allogeneic iPSC-based cell therapies and their potential in alleviating human diseases. Through these discussions, the paper aims to provide a comprehensive overview of the current status and future prospects of iPSC technology, offering valuable references for researchers and clinicians.